| 2008-12-12 |
Abbott Declares 340th Consecutive Quarterly Dividend |
| 2008-09-26 |
Standby Statement for Medical Nutrition products |
| 2008-09-18 |
Abbott Nutrition Statement on Infant Formula Contamination in China |
| 2008-08-07 |
Abbott Study Shows Investigational Heat-Stable Norvir® Tablet Provides Similar Drug Levels to Current Norvir Capsule |
| 2008-08-07 |
Abbott Virology is proud to sponsor The Electronic Wake, a unique summer event that will leave no one untouched |
| 2008-08-05 |
Abbott’s Kaletra® Tablet : Similar Clinical Results Across Race and Gender Lines |
| 2008-07-29 |
Abbott Prepares to Submit Heat-Stable Norvir® Tablet for Registration by End of Year |
| 2008-06-17 |
Abbott Nutrition Introduces New Web-Based Lifestyle Program for People with Diabetes |
| 2008-05-21 |
Abbott Presents Long-term Data from Extension Study Showing Adult Crohn’s Patients Treated with HUMIRA® (Adalimumab) Maintained Remission |
| 2008-01-24 |
HUMIRA® is Now Approved in Canada for the Treatment of Moderate-to-Severe Plaque Psoriasis |
| 2008-01-21 |
Health Canada approves HUMIRA® (adalimumab) for treatment of Crohn's disease |
| 2008-01-10 |
Abbott Named One the 50 Best Employers in Canada for Third Consecutive Year |